期刊文献+

C57BL/6小鼠PD-1基因敲除后炎症与心房电重构的关系研究

PD-1 Deficiency Results in Atrial Electricity Remodeling in C57BL/6 Mice
原文传递
导出
摘要 目的:研究C57BL/6小鼠在PD-1基因敲除后体内炎症升高对房颤发病易感性的影响。方法:对两组动物进行了观察:C57BL/6小鼠和C57BL/6-PD-1基因敲除小鼠(各组均为15只,雄性,6-8周龄)。应用流式细胞仪微球芯片捕获技术对比了实验组与对照组的血清炎性细胞因子表达水平,应用多导电生理记录仪检测了实验组与对照组心房有效不应期和有效不应期离散度。结果:和对照组相比较,C57BL/6-PD-1-/-小鼠血清炎性细胞因子水平明显升高,C57BL/6-PD-1-/-小鼠心房肌有效不应期较对照组减低,而有效不应期离散度则明显升高。结论:PD-1基因敲除后出现的机体内炎性细胞因子水平的升高导致了C57BL/6小鼠的心房电重构,并由此使得C57BL/6-PD-1-/-小鼠心房纤颤发病易感性升高。 Objective: To investigate the effect of PD-1 deficiency in the pathogenesis of atrial fibrillation. Methods: Two groups of mice were used to carry out our experiment: C57BL/6 group(15 mice, male, 6-8 weeks) and C57BL/6-PD-1-/- group(15 mice, male,6-8 weeks), the expression of inflammatory cytokines: interleukin(IL)-2,(IL)-4,(IL)-6,(IL)-10,(IL)-17, interferon(IFN)-γ and tumor necrosis factor(TNF)were determined by cytometric bead array, the atrial effective refractory period(AERPs) were determined by more conductive physiological recorder. Results: Inflammatory cytokines increased significantly in the PD-1-/-group compared with that in the C57BL/6 group; Mean while, the PD-1-/-group presented a shorter atrial effective refractory period and an increased dAERP. Conclusion:The higher level of inflammatory cytokines in the PD-1-/-mice results in atrial electricity remodeling in C57BL/6 mice, which lead to atrial fibrillation.
出处 《现代生物医学进展》 CAS 2014年第22期4249-4251,共3页 Progress in Modern Biomedicine
关键词 PD-1基因敲除 炎性细胞因子 心房电重构 心房纤颤 PD-1 deficiency Inflammatory cytokines Atrial electricity remodeling Atrial fibrillation
  • 相关文献

参考文献20

  • 1Richard LP Newly diagnosed atrial fibrillation[J]. New England Journal of Medicine, 2004,351(23): 2408-2416.
  • 2何森,王斯,陈晓平.心房颤动发病机制的研究进展[J].华西医学,2012,27(5):794-797. 被引量:20
  • 3Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study[J]. Circulation, 1998,98(10): 946-952.
  • 4高淑萍,葛利军,栾红,潘闽.心房颤动与炎症关系的研究进展[J].宁夏医学杂志,2011,33(2):182-183. 被引量:1
  • 5Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy C-reactiveDrotein attenuates nitric oxide production and inhibits angiogenesis[J]. Circulation, 2002, 106(8): 913-919.
  • 6Gianchecchi, Elena D, Domenico V, et al. Recent insights into the role of the PD-IIPD-Ll pathway in immunological tolerance and autoimmunity[J]. Autoimmunity Reviews, 20 13[ahead of publish).
  • 7Wang J, Okazaki 1M, Yoshida T, et al. PD-I deficiency results in the development offatal myocarditis in MRL mice[J]. Int Immunol, 2010, 22(6): 443-452.
  • 8Etzion Y, Mor M, Shalev A, et al. New insights into the atrial electrophysiology of rodents using a novel modality: the miniaturebipolar hook electrode[J]. Am J Physiol Heart Circ Physiol, 2008, 295 (4): H1460-469.
  • 9Riella LV, Paterson AM, Sharpe AH, et al. Role of the PD-I pathway in the immune response[J]. Am J Transplant, 2012,12(10): 2575-2587.
  • 10Chen PS, Turker I. Epicardial adipose tissue and neural mechanisms of atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2012, 5 (4): 618-620.

二级参考文献72

  • 1吴卫,柯丹,许春萱,邓玉莲,陈林,张建成,林亚洲,胡锡衷.Ⅰ型胶原和白细胞介素-1β在心房颤动患者心房中的表达[J].中华内科杂志,2006,45(10):807-810. 被引量:11
  • 2Goldstein RN,Ryu K,Khrestian C,et al.Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model[J].J Cardiovasc Electrophysiol,2008,19(1):74-81.
  • 3Hirayama Y,Atarashi H,Kobayashi Y,et al.Long-term effects of upstream therapy on paroxysmal atrial fibrillation in patients without overt heart diseases[J].Int Heart J,2009,50(2):141-151.
  • 4Kourliouros A,Valencia O,Hosseini MT,et al.Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery:A randomized controlled trial[J].J Thorac Cardiovasc Surg,2010(Epub ahead of print),111(1):244-248.
  • 5Kuhn EW,Liakopoulos OJ,Borys MJ,et al.Statins improve surgical ablation outcomes for atrial fibrillation in patients undergoing concomitant cardiac surgery[J].Interact Cardiovasc Thorac Surg,2010,11(1):24-28.
  • 6Maggioni AP,Fabbri G,Lucci D,et al.Effects of rosuvastatin on atrial fibrillation occurrence:ancillary results of the GISSI-HF trial[J].Eur Heart J,2009,30(19):2327-2336.
  • 7Hagiwara N.Inflammation and atrial fibrillation[J].Circ J,2010,74(2):246-247.
  • 8Pan M,Zhu JH,Jiang WP,et al.Inflammation:a possible pathogenic link to atrial fibrillation[J].Med Hypotheses,2006,67(6):1305-1307.
  • 9Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Circulation,2006,114(7):257-354.
  • 10Toutouzas K,Drakopoulou M,Dilaveris P,et al.Inflammation in lone atrial fibrillation:new insights by coronary sinus thermography[J].Int J Cardiol,2009,134(3):345-350.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部